Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism.
Mansour N, Mittermeier A, Walter R, Schachtner B, Rudolph J, Erber B, Schmidt VF, Heinrich D, Bruedgam D, Tschaidse L, Nowotny H, Bidlingmaier M, Kunz SL, Adolf C, Ricke J, Reincke M, Reisch N, Wildgruber M, Ingrisch M. Mansour N, et al. Among authors: heinrich d. Front Endocrinol (Lausanne). 2023 Aug 24;14:1244342. doi: 10.3389/fendo.2023.1244342. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37693351 Free PMC article.
Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: The salt CONNtrol trial.
Schneider H, Sarkis AL, Sturm L, Britz V, Lechner A, Potzel AL, Müller LM, Heinrich DA, Künzel H, Nowotny HF, Seiter TM, Kunz S, Bidlingmaier M, Reincke M, Adolf C. Schneider H, et al. J Intern Med. 2023 Jul;294(1):47-57. doi: 10.1111/joim.13618. Epub 2023 Mar 22. J Intern Med. 2023. PMID: 36945842 Clinical Trial.
Effect of mild cortisol cosecretion on body composition and metabolic parameters in patients with primary hyperaldosteronism.
Mansour N, Bruedgam D, Dischinger U, Kürzinger L, Adolf C, Walter R, Öcal O, Schmidt VF, Rudolph J, Ricke J, Reisch N, Reincke M, Wildgruber M, Heinrich D. Mansour N, et al. Among authors: heinrich d. Clin Endocrinol (Oxf). 2024 Mar;100(3):212-220. doi: 10.1111/cen.15013. Epub 2024 Jan 1. Clin Endocrinol (Oxf). 2024. PMID: 38164017
Assessing Lateralization Index of Adrenal Venous Sampling for Surgical Indication in Primary Aldosteronism.
Kobayashi H, Nakamura Y, Abe M, Ragnarsson O, Gkaniatsa E, Grytaas MA, Løvås K, Wada N, Ichijo T, Heinrich DA, Drake W, O'Toole S, Kocjan T, Kastelan D, Kraljevic I, Yamamoto K, Tsuiki M, Kloock S, Dischinger U, Parasiliti-Caprino M, Sven G, Spyroglou A, Furnica RM, Fallo F, Maiolino G, Kometani M, Wu VC, Beuschlein F, Reincke M, Naruse M. Kobayashi H, et al. Among authors: heinrich da. J Clin Endocrinol Metab. 2024 May 15:dgae336. doi: 10.1210/clinem/dgae336. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38747468
Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess.
Meng Y, Bilyal A, Chen L, Mederos Y Schnitzler M, Kocabiyik J, Gudermann T, Riols F, Haid M, Marques JG, Horak J, Koletzko B, Sun J, Beuschlein F, Heinrich DA, Adolf C, Reincke M, Schneider H. Meng Y, et al. Among authors: heinrich da. Atherosclerosis. 2024 Nov;398:118591. doi: 10.1016/j.atherosclerosis.2024.118591. Epub 2024 Sep 5. Atherosclerosis. 2024. PMID: 39277963 Free article.
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Gillessen S, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small E, Smith M, Sweeney CJ, Tombal B, Zilli T, Agarwal N, Antonarakis ES, Aparicio A, Armstrong AJ, Bastos DA, Attard G, Axcrona K, Ayadi M, Beltran H, Bjartell A, Blanchard P, Bourlon MT, Briganti A, Bulbul M, Buttigliero C, Caffo O, Castellano D, Castro E, Cheng HH, Chi KN, Clarke CS, Clarke N, de Bono JS, De Santis M, Duran I, Efstathiou E, Ekeke ON, El Nahas TIH, Emmett L, Fanti S, Fatiregun OA, Feng FY, Fong PCC, Fonteyne V, Fossati N, George DJ, Gleave ME, Gravis G, Halabi S, Heinrich D, Herrmann K, Hofman MS, Hope TA, Horvath LG, Hussain MHA, Jereczek-Fossa BA, Jones RJ, Joshua AM, Kanesvaran R, Keizman D, Khauli RB, Kramer G, Loeb S, Mahal BA, Maluf FC, Mateo J, Matheson D, Matikainen MP, McDermott R, McKay RR, Mehra N, Merseburger AS, Morgans AK, Morris MJ, Mrabti H, Mukherji D, Murphy DG, Murthy V, Mutambirwa SBA, Nguyen PL, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Renard-Penna R, Ryan CJ, Saad F, Sade JP, Sandhu S, Sartor OA, Schaeffer E, Scher HI, Sharifi N, Skoneczna IA, Soule HR, Spratt DE, Srinivas S, Sternberg CN, S… See abstract for full author list ➔ Gillessen S, et al. Among authors: heinrich d. Eur Urol. 2024 Oct 10:S0302-2838(24)02610-1. doi: 10.1016/j.eururo.2024.09.017. Online ahead of print. Eur Urol. 2024. PMID: 39394013 Free article.
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302).
Lara PN Jr, Villanueva L, Ibanez C, Erman M, Lee JL, Heinrich D, Lipatov ON, Gedye C, Gokmen E, Acevedo A, Semenov A, Park SH, Gafanov RA, Kose F, Jones M, Du X, Munteanu M, Perini R, Choueiri TK, Motzer RJ. Lara PN Jr, et al. Among authors: heinrich d. BMC Cancer. 2024 Jul 25;23(Suppl 1):1253. doi: 10.1186/s12885-023-10971-7. BMC Cancer. 2024. PMID: 39054430 Free PMC article. Clinical Trial.
Plain language summary of the results from the TALAPRO-2 study: Talazoparib plus enzalutamide versus placebo plus enzalutamide for patients with advanced prostate cancer.
Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, Szczylik C, De Giorgi U, Joung JY, Fong PCC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Lin X, Healy CG, Di Santo N, Zohren F, Fizazi K. Agarwal N, et al. Among authors: heinrich d. Future Oncol. 2024;20(29):2123-2135. doi: 10.1080/14796694.2024.2362108. Epub 2024 Jul 12. Future Oncol. 2024. PMID: 38995237 Free PMC article. Clinical Trial.
351 results